Breaking News: $IMMU Why Immunomedics Stock Is Screaming Higher Today
Shares of cancer specialist Immunomedics (NASDAQ: IMMU) rose by an astounding 106.4% in pre-market trading Monday morning. The biotech's shares are ripping higher this morning in response to a $21 billion buyout agreement with industry giant Gilead Sciences (NASDAQ: GILD) . Gilead report...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.